Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 298

    1.

    a-Series gangliosides mediate the effects of advanced glycation end products on pericyte and mesangial cell proliferation: a common mediator for retinal and renal microangiopathy?

    Masson E, Troncy L, Ruggiero D, Wiernsperger N, Lagarde M, El Bawab S.

    Diabetes. 2005 Jan;54(1):220-7.PMID: 15616032 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytes.

    Masson E, Wiernsperger N, Lagarde M, El Bawab S.

    Glycobiology. 2005 Jun;15(6):585-91. Epub 2004 Dec 29.PMID: 15625180 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Growth modulation of retinal microvascular cells by early and advanced glycation products.

    Ruggiero-Lopez D, Rellier N, Lecomte M, Lagarde M, Wiernsperger N.

    Diabetes Res Clin Pract. 1997 Jan;34(3):135-42.PMID: 9069564 [PubMed - indexed for MEDLINE]Related articles

    4.

    Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy.

    Chibber R, Molinatti PA, Rosatto N, Lambourne B, Kohner EM.

    Diabetologia. 1997 Feb;40(2):156-64.PMID: 9049475 [PubMed - indexed for MEDLINE]Related articles

    5.

    Glycosphingolipid changes induced by advanced glycation end-products.

    Natalizio A, Ruggiero D, Lecomte M, Lagarde M, Wiernsperger N.

    Biochem Biophys Res Commun. 2001 Feb 16;281(1):78-83.PMID: 11178963 [PubMed - indexed for MEDLINE]Related articles

    6.

    Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides.

    Masson E, Wiernsperger N, Lagarde M, El Bawab S.

    Biochem J. 2005 Jun 1;388(Pt 2):537-44.PMID: 15654767 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Ganglioside GM3 inhibits the high glucose- and TGF-beta1-induced proliferation of rat glomerular mesangial cells.

    Kwak DH, Lee S, Kim SJ, Ahn SH, Song JH, Choo YK, Choi BK, Jung KY.

    Life Sci. 2005 Sep 30;77(20):2540-51.PMID: 15939439 [PubMed - indexed for MEDLINE]Related articles

    8.

    Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

    Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.

    Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3972-8.PMID: 11053301 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Advanced glycation end products induce specific glycoprotein alterations in retinal microvascular cells.

    Rellier N, Ruggiero D, Lecomte M, Lagarde M, Wiernsperger N.

    Biochem Biophys Res Commun. 1997 Jun 18;235(2):281-5.PMID: 9199182 [PubMed - indexed for MEDLINE]Related articles

    10.

    Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.

    Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H.

    Am J Pathol. 1997 Feb;150(2):523-31.PMID: 9033268 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products.

    Paget C, Lecomte M, Ruggiero D, Wiernsperger N, Lagarde M.

    Free Radic Biol Med. 1998 Jul 1;25(1):121-9.PMID: 9655530 [PubMed - indexed for MEDLINE]Related articles

    13.

    The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression.

    Pugliese G, Pricci F, Leto G, Amadio L, Iacobini C, Romeo G, Lenti L, Sale P, Gradini R, Liu FT, Di Mario U.

    Diabetes. 2000 Jul;49(7):1249-57.PMID: 10909985 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy.

    Yatoh S, Mizutani M, Yokoo T, Kozawa T, Sone H, Toyoshima H, Suzuki S, Shimano H, Kawakami Y, Okuda Y, Yamada N.

    Diabetes Metab Res Rev. 2006 Jan-Feb;22(1):38-45.PMID: 15892182 [PubMed - indexed for MEDLINE]Related articles

    15.

    Bimodal effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipids.

    Geoffroy K, Wiernsperger N, Lagarde M, El Bawab S.

    J Biol Chem. 2004 Aug 13;279(33):34343-52. Epub 2004 Jun 7.PMID: 15184394 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Mechanism for the negative regulation of cell proliferation by ganglioside GM3 in high glucose-treated glomerular mesangial cells.

    Rho YI, Kwak DH, Lee S, Ahn SH, Baek SH, Song JH, Choo YK, Choi BK, Jung KY.

    Life Sci. 2004 May 21;75(1):51-62.PMID: 15102521 [PubMed - indexed for MEDLINE]Related articles

    17.

    Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.

    Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H.

    J Clin Invest. 2001 Jul;108(2):261-8.PMID: 11457879 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes.

    Chen BH, Jiang DY, Tang LS.

    Life Sci. 2006 Aug 8;79(11):1040-8. Epub 2006 Mar 24.PMID: 16674981 [PubMed - indexed for MEDLINE]Related articles

    19.

    Roles of the AGE-RAGE system in vascular injury in diabetes.

    Yamamoto Y, Yamagishi S, Yonekura H, Doi T, Tsuji H, Kato I, Takasawa S, Okamoto H, Abedin J, Tanaka N, Sakurai S, Migita H, Unoki H, Wang H, Zenda T, Wu PS, Segawa Y, Higashide T, Kawasaki K, Yamamoto H.

    Ann N Y Acad Sci. 2000 May;902:163-70; discussion 170-2.PMID: 10865836 [PubMed - indexed for MEDLINE]Related articles

    20.

    Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: a factor in diabetic retinopathy.

    Xu X, Li Z, Luo D, Huang Y, Zhu J, Wang X, Hu H, Patrick CP.

    Graefes Arch Clin Exp Ophthalmol. 2003 Jan;241(1):56-62. Epub 2002 Dec 4.PMID: 12545293 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data